Learn more

NAT CANCER CENTER JAPAN

Overview
  • Total Patents
    38
  • GoodIP Patent Rank
    40,673
  • Filing trend
    ⇧ 100.0%
About

NAT CANCER CENTER JAPAN has a total of 38 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HOX THERAPEUTICS LTD, BERGSTEIN IVAN and COUNCIL QUEENSLAND INST MEDICAL RES.

Patent filings per year

Chart showing NAT CANCER CENTER JAPANs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Matsumura Yasuhiro 20
#2 Yasunaga Masahiro 14
#3 Saijo Shinji 12
#4 Manabe Shino 12
#5 Hanaoka Shingo 9
#6 Nishikawa Hiroyoshi 7
#7 Fuchigami Hirobumi 6
#8 Matsuda Atsushi 4
#9 Fukuda Kyoko 4
#10 Kobayashi Tamiyo 4

Latest patents

Publication Filing date Title
TW201922796A Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and cancer drug including same
TW201906820A Carcinogenic inhibitor
EP3620471A1 Plasmin-cleavable anti-insoluble fibrin antibody-drug conjugate
CN110494750A The analysis system and program of the detection method of responsiveness regulatory T cells, the analytical equipment of responsiveness regulatory T cells, responsiveness regulatory T cells
WO2018159808A1 Antibody-drug conjugate of anti-il-7r antibody, and pharmaceutical composition for treating cancer or inflammation and containing antibody-drug conjugate of anti-il-7r antibody and cytotoxic drug
EP3578650A1 Novel t-cell receptor
WO2018131659A1 Immunotherapeutic agent
WO2018034259A1 Antibody binding to tmem132a, anticancer agent, and cancer test method
WO2017154868A1 Anti-tmem-180 antibody, anticancer agent, and test method for cancer
CA3010808A1 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound